查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1722809

空心胶囊市场规模、份额、趋势及预测（按类型、原料、功能、治疗应用、最终用户和地区），2025 年至 2033 年

Empty Capsules Market Size, Share, Trends and Forecast by Type, Raw Material, Functionality, Therapeutic Application, End User, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 150 Pages | 商品交期: 2-3个工作天内

价格

2024 年全球空心胶囊市场规模价值 32.6 亿美元。展望未来， IMARC Group估计到 2033 年市场规模将达到 56.7 亿美元，2025 年至 2033 年的复合年增长率为 6.28%。北美目前占据市场主导地位，2024 年的市占率将超过 34.5%。胶囊中胶囊技术的兴起，确保了患者的胃肠道安全，再加上医疗保健行业的许多进步，主要推动了该地区市场的发展。

空心胶囊市场分析：

主要市场驱动因素：慢性病盛行率的上升是推动全球市场发展的主要动力。此外，非明胶胶囊（如羟丙基甲基纤维素（HPMC））由于其透明度、适中的强度、耐油脂特性等而日益普及，也是另一个重要的成长诱导因素。

主要市场趋势：医疗保健领域的主要参与者对引进创新疗法和药物的广泛投资是推动市场发展的新兴趋势之一。此外，速释胶囊的发展也对市场成长产生了正面影响。

竞争格局：全球市场上一些知名的公司包括 ACG Associated Capsules Pvt。 Ltd.、Bright Pharma Caps Inc.、CapsCanada Corporation、HealthCaps India Limited、Lonza Group AG、Medicaps Limited、Qualicaps Co. Ltd.（三菱化学控股公司）、Nectar Lifesciences Limited、Roxlor LLC、山西广生药用胶囊有限公司、Snail Pharma Industry Co. Ltd、Suheung Co. Ltd 等。

地理趋势：由于注重健康的人群对膳食补充剂的倾向性日益增强，北美在市场上占据明显主导地位。除此之外，空胶囊供应商和明胶製造商之间的各种策略合作也促进了区域市场的成长。

挑战与机会：空心胶囊市场面临的主要挑战之一是确保胶囊的稳定性以及与多种活性药物成分（API）的兼容性。然而，材料科学的不断进步，开发出创新的胶囊材料和配方，增强稳定性并减少与各种 API 的相互作用，预计将在未来几年推动市场发展。

空心胶囊市场趋势：

慢性病的发生

老年人口的不断增长使得易患慢性疾病的人群对以胶囊形式生产具有治疗效果的药物的需求不断增加，因为与其他口服剂型相比，胶囊易于吞嚥并且溶解时间更快。根据世界卫生组织 (WHO) 的数据，预计 2020 年至 2050 年间，80 岁或以上人口的数量将增加两倍，达到约 4.26 亿。此外，根据美国人口参考局《人口公报-老化》显示，到2060年，美国65岁及以上人口预计将从2018年的5,200万人增加近一倍至9,500万人。此外，心血管疾病（CVD）在全球范围内非常普遍。根据世界卫生组织2019年发布的资料，估计每年有1,790万人因心血管疾病发生率上升而死亡，预计到2030年这一数字将增长到2,360多万人。此外，根据英国心臟基金会中心的数据，2021年英国约有760万人患有心臟和循环系统疾病。因此，这些病例的发生率不断上升，促进了心血管治疗药物的有效治疗，为空心胶囊市场前景提供了积极的推动力。

新产品发布

製药业先进封装解决方案的引入正在推动市场的发展。主要参与者正在开发增强型空胶囊变体，例如 HPMC 胶囊，作为硬明胶胶囊的素食替代品，并满足某些饮食和文化需求。例如，Capsugel 是一家着名的空胶囊製造商，拥有 20 多年的硬明胶胶囊製造经验及其他技术，提供一系列用于吸入和口服药物应用的羟丙基甲基纤维素 (HPMC) 胶囊。另一个例子是 ACG 于 2022 年 3 月开发的 ACGcaps NTone，它提供源自可食用来源的天然色素选择，吸引註重健康的人士。此外，作为合约 HPMC 和硬明胶胶囊製造服务的主要参与者之一，Suheung Capsule 为製药业提供高度稳定的硬明胶胶囊壳材料。除此之外，欧洲药品管理局（EMA）和美国食品药物管理局（FDA）越来越多的监管批准正在简化新配方的流程，这反过来又是空胶囊市场近期的机会之一。例如，2020年4月，硬胶囊和製药相关设备製造商之一Qualicaps与该地区多家领先公司签署了代理和分销合作协议，扩大了其在中东和非洲的业务。同样，2020年8月，雷迪博士实验室获得美国FDA批准，开发可用于治疗胱胺酸尿症和威尔逊氏症的仿製药青霉胺胶囊。

采用膳食补充剂

胶囊形式的药妆品和营养保健品（例如 CosmoPod 胶囊和鳕鱼肝油胶囊）的日益流行，成为重要的成长诱导因素。根据 IMARC 发布的报告，2023 年全球营养保健品市场规模达 4,685 亿美元。展望未来， IMARC Group预计到 2032 年市场规模将达到 8,563 亿美元，2024-2032 年期间的成长率 (CAGR) 为 6.7%。因此，以胶囊形式推出的补充剂为新配方提供了有利可图的机会，从而推动了空胶囊市场的需求。例如，2023 年 12 月，总部位于孟买的胶囊製造供应商之一 ACG 开发了一种新颖的营养保健品设计，采用并排技术将胶囊分成两个隔间，从而可以将液体和粉末等两种不同形式的成分製成一个胶囊。除此之外，膳食补充剂标籤资料库 (DSLD) 的资料显示，大约有 50,000 种膳食补充剂胶囊、软胶囊、片剂、粉末、液体、软糖和小包装产品可供选择。这些产品大多为单一维生素、复合维生素、胺基酸、草药、复合矿物质等多种剂型。此外，DSLD资料显示，有超过 17,000 种产品以胶囊形式提供，属于多个类别，占所有剂型的 34%。这反过来又推动了全球市场的发展。

空心胶囊市场细分：

按类型分列：

  • 明胶胶囊
  • 非明胶胶囊

目前，明胶胶囊占据最大的市场份额

明胶胶囊，也称为凝胶帽，是营养保健品和製药行业常用的一种口服剂型，因为它使用方便、用途广泛，并且能够掩盖封装物质的不良味道和气味。此外，它们通常有硬质和软质两种形式。硬明胶胶囊广泛用于干燥、粉状成分和颗粒，而软明胶胶囊则非常适合油和液体配方。具有最佳特性（例如提高的稳定性和改进的释放特性）的明胶胶囊的推出正在促进该领域的成长。例如，Suheung 等公司提供为优化稳定性而製造的 EMBO CAPS 胶囊。这些胶囊也采用高级原料生产，包括来自 Suheung 子公司 Geltech 的明胶。此外，严格的规格合规性和电脑化的原料交叉混合确保只有符合精确要求的粉末才能到达胶囊机。除此之外，2023年2月，Vivion公司推出了多种空心明胶胶囊。

依原料分类：

  • 猪肉
  • 牛肉
  • 骨
  • 羟丙基甲基纤维素（HPMC）
  • 其他的

其中，猪肉在空心胶囊市场份额中占据明显主导地位

猪肉，特别是猪肉明胶，由于其广泛的可用性和优异的胶凝性能，在市场份额中占据明显主导地位，这对于胶囊製造至关重要。猪明胶因其稳定的品质和能够形成在胃中迅速溶解的坚固而柔韧的胶囊的能力而受到青睐。例如，Capsugel 在其广泛使用的胶囊中采用猪肉明胶，从而确保可靠的性能。此外，2021 年 11 月，国际明胶製造商协会报告称，包括胶囊在内的药物应用中使用的明胶约 85% 来自猪肉。这种主导地位也得益于完善的供应链以及与牛明胶或鱼明胶等其他来源相比猪明胶较低的生产成本。儘管由于饮食限制和道德问题，人们对替代来源的兴趣日益浓厚，但猪明胶仍然是业界的首选。

按功能分类：

  • 速释胶囊
  • 缓释胶囊
  • 缓释胶囊

目前，速释胶囊占据全球大部分市场份额

对需要快速起效的药物传输需求的不断增长促进了这一领域的成长。速释胶囊在胃中快速溶解，迅速释放内容物，快速发挥治疗效果，使其成为各种药品和营养保健产品的理想选择。例如，2022 年 8 月，ACG 推出了其速释胶囊系列 ACGcaps IR，该系列专门设计用于优化活性成分的释放特性，从而提高其功效和患者依从性。同样，2023 年 1 月，Capsugel 推出了具有速释特性的 Vcaps Plus 胶囊，专为高速填充製程而设计，可确保快速溶解和生物利用度。这些创新满足了对有效和快速起效药物日益增长的需求，从而提高了空胶囊市场的近期价格。

依治疗应用分类：

  • 抗生素和抗菌药物
  • 维生素和膳食补充剂
  • 抗酸剂和抗胀气剂
  • 心血管治疗药物
  • 其他的

阿莫西林等抗生素胶囊的使用日益增多，由于其易于吞嚥和剂型可控，有助于提高患者的依从性。此外，由于消费者对健康和保健的关注度日益提高，维生素和膳食补充剂也占据了很大的市场份额。胶囊提供了一种方便的方式来获取必需营养素，例如通常以胶囊形式存在的 Omega-3 脂肪酸和维生素 D。抗酸剂和抗胀气剂可受益于胶囊快速缓解消化问题的能力。在心血管治疗中，它们确保准确地输送他汀类药物和抗高血压药物，这些药物对于治疗慢性心臟病至关重要。除此之外，其他治疗领域，包括疼痛管理和荷尔蒙疗法，也利用胶囊的多功能性和药物传递的有效性，预计这将在未来几年增加空胶囊市场的收入。

按最终用户分类：

  • 製药业
  • 营养保健品产业
  • 化妆品产业
  • 其他的

目前，製药业占据全球大部分市场份额

根据空胶囊市场统计数据，对患者友善递送方式的需求不断增加，正在刺激市场的发展。空胶囊为封装各种类型的药物（从粉末和颗粒到液体和半固体）提供了可靠的形式。例如，2023 年 9 月，龙沙报告称，其 Capsugel 硬明胶胶囊的需求大幅增加，这得益于其在新型药物配方和临床试验中的应用。这些胶囊因其稳定的性能和与多种活性药物成分 (API) 的兼容性而受到青睐。同样，Qualicaps 开发了新系列的 Quali-G 硬明胶胶囊，专为需要精确剂量和增强稳定性的高效药物而设计。製药业的主要参与者也利用空胶囊进行控释製剂，以提高治疗效果和患者遵从性。

按地区划分：

  • 北美洲
  • 美国
  • 加拿大
  • 亚太
  • 中国
  • 日本
  • 印度
  • 韩国
  • 澳洲
  • 印尼
  • 其他的
  • 欧洲
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙
  • 俄罗斯
  • 其他的
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 其他的
  • 中东和非洲

根据空心胶囊市场概况，北美目前占据全球市场份额的主导地位

市场研究报告也对所有主要区域市场进行了全面分析，包括北美（美国和加拿大）；亚太地区（中国、日本、印度、韩国、澳洲、印尼等）；欧洲（德国、法国、英国、义大利、西班牙、俄罗斯等）；拉丁美洲（巴西、墨西哥等）；以及中东和非洲。报告显示，北美占据最大的市场份额。

慢性病发病率的上升以及美国老年人口的扩大正在刺激区域市场的发展。根据美国人口参考局的《人口公报—老化》显示，到 2060 年，美国 65 岁及以上人口数量预计将从 2018 年的 5,200 万人增加近一倍至 9,500 万人。除此之外，对胶囊型营养保健品配方的需求不断增长也是另一个重要的成长诱导因素。根据CRN消费者调查，77%的美国人表示在2019年食用了膳食补充剂。此外，调查也显示，维生素和矿物质是同年美国民众最常食用的补充剂，占膳食补充剂总消费量的76%。除此之外，加拿大结构良好的医疗保健系统也鼓励对研发活动的投资，预计这将在预测期内推动北美空心胶囊市场的发展。

竞争格局：

市场研究报告对竞争格局进行了全面的分析。也提供了所有主要空心胶囊市场公司的详细资料。市场中的一些主要参与者包括：

  • ACG Associated Capsules Pvt.有限公司
  • 光明製药胶囊公司
  • 加拿大Caps公司
  • HealthCaps印度有限公司
  • 龙沙集团
  • Medicaps有限公司
  • Qualicaps Co. Ltd.（三菱化学控股公司）
  • Nectar生命科学有限公司
  • 罗克斯洛有限责任公司
  • 山西广生胶囊有限公司
  • 蜗牛药业有限公司
  • 瑞兴有限公司
  • 苏尼尔医疗保健有限公司

本报告回答的关键问题

  • 什么是空心胶囊
  • 空心胶囊市场有多大
  • 2025-2033年全球空心胶囊市场的预期成长率是多少
  • 推动全球空心胶囊市场的关键因素有哪些
  • 根据类型，全球空心胶囊市场的主要细分市场是什么
  • 根据原料，全球空心胶囊市场的主要细分市场是什么
  • 从功能角度来看，全球空心胶囊市场的主要细分市场是什么
  • 根据最终用户来看，全球空心胶囊市场的主要细分市场是什么
  • 全球空心胶囊市场的主要区域有哪些
  • 10. 全球空心胶囊市场的主要参与者/公司有哪些？

本报告回答的关键问题

  • 什么是空胶囊？空心胶囊市场有多大？
  • 2025 年至 2033 年期间全球空胶囊市场的预期成长率为何？
  • 推动全球空心胶囊市场发展的关键因素有哪些？
  • 根据类型，全球空胶囊市场的主要细分市场是什么？
  • 基于原料，全球空心胶囊市场的主要细分市场是什么？
  • 从功能性角度来看，全球空胶囊市场的主要细分市场是什么？
  • 根据最终用户来看，全球空胶囊市场的主要细分市场是什么？
  • 全球空心胶囊市场的主要区域有哪些？
  • 全球空心胶囊市场的主要参与者/公司有哪些？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球空心胶囊市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场细分：依类型

  • 明胶胶囊
  • 非明胶胶囊

第七章：市场区隔：依原料

  • 猪肉
  • 牛肉
  • 骨
  • 羟丙基甲基纤维素（HPMC）
  • 其他的

第八章：市场区隔：依功能

  • 速释胶囊
  • 缓释胶囊
  • 缓释胶囊

第九章：市场区隔：依治疗应用

  • 抗生素和抗菌药物
  • 维生素和膳食补充剂
  • 抗酸剂和抗胀气剂
  • 心血管治疗药物
  • 其他的

第十章：市场区隔：依最终用户

  • 製药业
  • 营养保健品产业
  • 化妆品产业
  • 其他的

第 11 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第 12 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 13 章：价值链分析

第 14 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 15 章：价格分析

第 16 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • ACG Associated Capsules Pvt. Ltd.
    • Bright Pharma Caps Inc.
    • CapsCanada Corporation
    • HealthCaps India Limited
    • Lonza Group AG
    • Medicaps Limited
    • Qualicaps Co. Ltd. (Mitsubishi Chemical Holdings Corporation)
    • Nectar Lifesciences Limited
    • Roxlor LLC
    • Shanxi Guangsheng Medicinal Capsules Co. Ltd
    • Snail Pharma Industry Co. Ltd
    • Suheung Co. Ltd
    • Sunil Healthcare Limited
Product Code: SR112025A5187

The global empty capsules market size was valued at USD 3.26 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 5.67 Billion by 2033, exhibiting a CAGR of 6.28% from 2025-2033. North America currently dominates the market, holding a market share of over 34.5% in 2024. The emerging popularity of capsule-in-capsule technology to ensure the gastrointestinal safety of patients, coupled with numerous advancements in the healthcare industry is primarily fueling the market in this region.

Empty Capsules Market Analysis:

Major Market Drivers: The increasing prevalence of chronic diseases is primarily driving the global market. Moreover, the rising adoption of non-gelatin capsules, such as hydroxypropyl methylcellulose (HPMC), due to its transparency, moderate strength, resistance to oil and fat properties, etc., is also acting as another significant growth-inducing factor.

Key Market Trends: The widespread investments by key players in the healthcare sector for introducing innovative therapeutics and pharmaceutical drugs are among the emerging trends bolstering the market. Furthermore, the development of immediate-release capsules is also positively influencing the market growth.

Competitive Landscape: Some of the prominent companies in the global market include ACG Associated Capsules Pvt. Ltd., Bright Pharma Caps Inc., CapsCanada Corporation, HealthCaps India Limited, Lonza Group AG, Medicaps Limited, Qualicaps Co. Ltd. (Mitsubishi Chemical Holdings Corporation), Nectar Lifesciences Limited, Roxlor LLC, Shanxi Guangsheng Medicinal Capsules Co. Ltd, Snail Pharma Industry Co. Ltd, Suheung Co. Ltd, and Sunil Healthcare Limited, among many others.

Geographical Trends: North America exhibits a clear dominance in the market, owing to the increasing inclination among health-conscious individuals towards dietary supplements. Besides this, various strategic collaborations between empty capsule suppliers and gelatin manufacturers are contributing to the growth of the regional market.

Challenges and Opportunities: One of the major challenges in the empty capsules market is ensuring the stability and compatibility of capsules with a wide range of active pharmaceutical ingredients (APIs). However, continuous improvements in material science to develop innovative capsule materials and formulations that enhance stability and reduce interactions with diverse APIs are expected to fuel the market in the coming years.

Empty Capsules Market Trends:

Occurrence of Chronic Diseases

The expanding geriatric population who are susceptible to developing associated chronic conditions is escalating the demand for the production of therapeutically effective medicines in the form of capsules, as they are easy to swallow and have faster dissolution times compared to other oral dosage forms. According to the World Health Organization (WHO), the number of individuals aged 80 years or older is anticipated to triple between 2020 and 2050, reaching roughly about 426 million. Besides this, as stated by the Population Reference Bureau's Population Bulletin-Aging in the United States, the Americans aged 65 years and older are expected to nearly double from 52 million in 2018 to 95 million by 2060. Additionally, cardiovascular diseases (CVDs) are highly prevalent globally. As per the data published by the World Health Organization in 2019, an estimated 17.9 million people die each year due to the elevating incidences of cardiovascular diseases, and the number is projected to grow approximately to more than 23.6 million by 2030. Moreover, according to the British Heart Foundation Centre, around 7.6 million individuals were living with heart and circulatory diseases in 2021 across the United Kingdom. As a result, the rising incidences of these cases are bolstering the adoption of cardiovascular therapy drugs for effective treatment, which is providing a positive empty capsules market outlook.

Novel Product Launches

The introduction of advanced encapsulation solutions in the pharmaceutical industry is fueling the market. Key players are developing enhanced empty capsule variants, such as HPMC capsules, that serve as vegetarian alternatives to hard gelatin capsules and satisfy certain dietary and cultural needs. For example, Capsugel, one of the prominent empty capsules manufacturers with more than 20 years of experience in hard gelatin capsule manufacturing, amongst other technologies, provides a range of hydroxy propyl methyl cellulose (HPMC) capsules for inhalation and oral pharmaceutical applications. Another instance is the development of ACGcaps NTone by ACG in March 2022, which offers natural color options derived from edible sources, appealing to health-conscious individuals. Moreover, Suheung Capsule, one of the key players in contract HPMC and hard gelatin capsule manufacturing services, offers highly stable hard gelatin capsule shell materials for the pharmaceutical industry. Apart from this, the increasing number of regulatory approvals from the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA) are simplifying the process of new formulations, which, in turn, is one of the empty capsules market recent opportunities. For example, in April 2020, Qualicaps, one of the manufacturers of hard capsules and pharmaceutical-related equipment, expanded its presence in the Middle East and Africa after signing agency and distribution partnership agreements with a number of leading companies operating in the region. Similarly, in August 2020, Dr. Reddy Laboratories received USFDA approval for the development of generic Penicillamine capsules that can be used for the treatment of cystinuria and Wilson's disease.

Adoption of Dietary Supplements

The inflating popularity of cosmeceuticals and nutraceuticals that are preferred in capsule forms, such as CosmoPod capsules and cod liver oil capsules, respectively, is acting as a significant growth-inducing factor. According to the report published by IMARC, the global nutraceuticals market size reached US$ 468.5 Billion in 2023. Looking forward, IMARC Group anticipated the market to reach US$ 856.3 Billion by 2032, exhibiting a growth rate (CAGR) of 6.7% during 2024-2032. Consequently, the introduction of supplements in the form of capsules that allow lucrative opportunities for new formulations is propelling the empty capsules market demand. For instance, in December 2023, ACG, one of the Mumbai-based capsule manufacturing providers, developed a novel design for nutraceuticals by using side by sides technology that separates capsules into two compartments, thereby enabling ingredients of two different forms, such as liquid and powder, to be made into one capsule. Apart from this, the data from the Dietary Supplements Label Database (DSLD) revealed that roughly 50,000 dietary supplement capsules, softgel, tablet, powder, liquid, gummy, and packet products are available. Most of these products are numerous dosage forms of single vitamins, multi-vitamins, amino acids, herbals, multi-minerals, etc. Moreover, the DSLD data stated that more than 17,000 products are available as capsules under several categories, accounting for a 34 % share among all dosage forms. This, in turn, is driving the global market.

Empty Capsules Market Segmentation:

Breakup by Type:

  • Gelatin Capsule
  • Non-gelatin Capsule

Currently, gelatin capsule accounts for the largest market share

Gelatin capsules, also called gel caps, represent a popular form of oral dosage used in the nutraceutical and pharmaceutical industries due to their ease of use, versatility, and ability to mask unpleasant tastes and odors of enclosed substances. Moreover, they are commonly available in both hard and soft forms. Hard gelatin capsules are widely used for dry, powdered ingredients and pellets, while soft gelatin capsules are ideal for oils and liquid-based formulations. The introduction of gelatin capsules with optimal properties, such as improved stability and modified release profiles, is augmenting the segment's growth. For instance, companies, such as Suheung, offer EMBO CAPS capsules that are manufactured to optimize stability. These capsules are also produced by adopting high-grade raw materials, including gelatine, which is sourced from Geltech, a subsidiary of Suheung. In addition, stringent specification compliance and computerized raw material cross-blending ensure only powders that meet the exact requirements can reach the capsulation machines. Apart from this, in February 2023, Vivion, Inc. introduced a wide range of empty gelatin capsules.

Breakup by Raw Material:

  • Pig Meat
  • Bovine Meat
  • Bone
  • Hydroxypropyl Methylcellulose (HPMC)
  • Others

Among these, pig meat exhibits a clear dominance in the empty capsules market share

Pig meat, specifically pork-derived gelatin, exhibits a clear dominance in the market share, owing to its widespread availability and excellent gelling properties, which are crucial for capsule manufacturing. Pork gelatin is favored for its consistent quality and ability to form strong and flexible capsules that dissolve readily in the stomach. For example, Capsugel adopts pork-derived gelatin in their widely used capsules, thereby ensuring reliable performance. Additionally, in November 2021, the International Gelatin Manufacturers Association reported that approximately 85% of the gelatin used in pharmaceutical applications, including capsules, is derived from pork. This dominance is also driven by the well-established supply chains and lower production costs associated with pork gelatin compared to other sources, such as bovine or fish gelatin. Despite the growing interest in alternative sources due to dietary restrictions and ethical concerns, pork gelatin remains the preferred choice in the industry.

Breakup by Functionality:

  • Immediate-release Capsules
  • Sustained-release Capsules
  • Delayed-release Capsules

Currently, immediate-release capsules account for the majority of the global market share

The inflating need for delivering medications that require rapid onset of action is augmenting the growth in this segment. Immediate-release capsules dissolve quickly in the stomach, releasing their contents promptly for fast therapeutic effects, which makes them ideal for a broad range of pharmaceutical and nutraceutical products. For example, in August 2022, ACG launched its line of immediate-release capsules, ACGcaps IR, which are specifically designed to optimize the release profile of active ingredients, enhancing their efficacy and patient compliance. Similarly, in January 2023, Capsugel introduced their Vcaps Plus capsules with immediate-release properties, tailored for high-speed filling processes and ensuring quick dissolution and bioavailability. These innovations cater to the escalating demand for effective and fast-acting medications, which is elevating the empty capsules market's recent price.

Breakup by Therapeutic Application:

  • Antibiotic and Antibacterial Drugs
  • Vitamins and Dietary Supplements
  • Antacid and Antiflatulent Preparations
  • Cardiovascular Therapy Drugs
  • Others

The rising usage of capsules in antibiotics like amoxicillin helps to improve patient adherence due to their ease of swallowing and controlled dosage forms. Additionally, vitamins and dietary supplements also comprise a large portion of the market, driven by the growing consumer focus on health and wellness. Capsules offer a convenient way to consume essential nutrients, such as omega-3 fatty acids and vitamin D, which are often found in capsule form. Antacid and antiflatulent preparations benefit from the ability of capsules to deliver fast-acting relief from digestive issues. In cardiovascular therapy, they ensure the accurate delivery of drugs like statins and antihypertensives, which are crucial for managing chronic heart conditions. Besides this, other therapeutic areas, including pain management and hormonal therapies, utilize capsules for their versatility and efficacy in drug delivery, which is expected to bolster the empty capsules market revenue in the coming years.

Breakup by End User:

  • Pharmaceutical Industry
  • Nutraceutical Industry
  • Cosmetics Industry
  • Others

Currently, the pharmaceutical industry account for the majority of the global market share

As per the empty capsules market statistics, the escalating demand for patient-friendly delivery methods is stimulating the market. Empty capsules provide a reliable form for encapsulating various types of medications, from powders and granules to liquids and semisolids. For instance, in September 2023, Lonza reported a significant increase in demand for its Capsugel hard gelatin capsules, driven by their use in novel drug formulations and clinical trials. These capsules are favored for their consistent performance and compatibility with a wide range of active pharmaceutical ingredients (APIs). Similarly, Qualicaps developed its new line of Quali-G hard gelatin capsules, which is designed specifically for high-potency drugs, which require precise dosing and enhanced stability. Key players in the pharmaceutical industry also leverage empty capsules for controlled-release formulations, enhancing therapeutic efficacy and patient compliance.

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

According to the empty capsules market overview, North America currently dominates the global market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

The increasing incidences of chronic diseases, along with the expanding geriatric population in the United States, are stimulating the regional market. According to the Population Reference Bureau's Population Bulletin-Aging in the United States, the number of individuals aged 65 years and older is expected to nearly double from 52 million in 2018 to 95 million by 2060. Besides this, the escalating demand for capsule-based nutraceutical formulations is also acting as another significant growth-inducing factor. As per the CRN Consumer Survey, 77% of Americans reported consuming dietary supplements in 2019. Moreover, the survey revealed that vitamins and minerals were the most common supplements consumed by the population across the United States in the same year, accounting for 76% of total dietary supplement consumption. Apart from this, the well-structured healthcare systems in Canada are also encouraging investments in R&D activities, which are anticipated to fuel the empty capsules market in North America over the forecasted period.

Competitive Landscape:

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major empty capsules market companies have also been provided. Some of the key players in the market include:

  • ACG Associated Capsules Pvt. Ltd.
  • Bright Pharma Caps Inc.
  • CapsCanada Corporation
  • HealthCaps India Limited
  • Lonza Group AG
  • Medicaps Limited
  • Qualicaps Co. Ltd. (Mitsubishi Chemical Holdings Corporation)
  • Nectar Lifesciences Limited
  • Roxlor LLC
  • Shanxi Guangsheng Medicinal Capsules Co. Ltd
  • Snail Pharma Industry Co. Ltd
  • Suheung Co. Ltd
  • Sunil Healthcare Limited

Key Questions Answered in This Report

  • 1.What are empty capsules?
  • 2.How big is the empty capsules market?
  • 3.What is the expected growth rate of the global empty capsules market during 2025-2033?
  • 4.What are the key factors driving the global empty capsules market?
  • 5.What is the leading segment of the global empty capsules market based on type?
  • 6.What is the leading segment of the global empty capsules market based on raw material?
  • 7.What is the leading segment of the global empty capsules market based on functionality?
  • 8.What is the leading segment of the global empty capsules market based on end user?
  • 9.What are the key regions in the global empty capsules market?
  • 10.Who are the key players/companies in the global empty capsules market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Empty Capsules Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Gelatin Capsule
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Non-gelatin Capsule
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Raw Material

  • 7.1 Pig Meat
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Bovine Meat
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Bone
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Hydroxypropyl Methylcellulose (HPMC)
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Functionality

  • 8.1 Immediate-release Capsules
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Sustained-release Capsules
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Delayed-release Capsules
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Therapeutic Application

  • 9.1 Antibiotic and Antibacterial Drugs
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Vitamins and Dietary Supplements
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Antacid and Antiflatulent Preparations
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Cardiovascular Therapy Drugs
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Others
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by End User

  • 10.1 Pharmaceutical Industry
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Nutraceutical Industry
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Cosmetics Industry
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Others
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 ACG Associated Capsules Pvt. Ltd.
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
    • 16.3.2 Bright Pharma Caps Inc.
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
    • 16.3.3 CapsCanada Corporation
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
    • 16.3.4 HealthCaps India Limited
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
    • 16.3.5 Lonza Group AG
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
      • 16.3.5.3 Financials
      • 16.3.5.4 SWOT Analysis
    • 16.3.6 Medicaps Limited
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
      • 16.3.6.3 Financials
    • 16.3.7 Qualicaps Co. Ltd. (Mitsubishi Chemical Holdings Corporation)
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
    • 16.3.8 Nectar Lifesciences Limited
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials
    • 16.3.9 Roxlor LLC
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
    • 16.3.10 Shanxi Guangsheng Medicinal Capsules Co. Ltd
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
    • 16.3.11 Snail Pharma Industry Co. Ltd
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
    • 16.3.12 Suheung Co. Ltd
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio
    • 16.3.13 Sunil Healthcare Limited
      • 16.3.13.1 Company Overview
      • 16.3.13.2 Product Portfolio
      • 16.3.13.3 Financials

List of Figures

  • Figure 1: Global: Empty Capsules Market: Major Drivers and Challenges
  • Figure 2: Global: Empty Capsules Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Empty Capsules Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Empty Capsules Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Empty Capsules Market: Breakup by Raw Material (in %), 2024
  • Figure 6: Global: Empty Capsules Market: Breakup by Functionality (in %), 2024
  • Figure 7: Global: Empty Capsules Market: Breakup by Therapeutic Application (in %), 2024
  • Figure 8: Global: Empty Capsules Market: Breakup by End User (in %), 2024
  • Figure 9: Global: Empty Capsules Market: Breakup by Region (in %), 2024
  • Figure 10: Global: Empty Capsules (Gelatin Capsule) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Empty Capsules (Gelatin Capsule) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Empty Capsules (Non-gelatin Capsule) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Empty Capsules (Non-gelatin Capsule) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Empty Capsules (Pig Meat) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Empty Capsules (Pig Meat) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Empty Capsules (Bovine Meat) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Empty Capsules (Bovine Meat) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Empty Capsules (Bone) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Empty Capsules (Bone) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Empty Capsules (Hydroxypropyl Methylcellulose-HPMC) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Empty Capsules (Hydroxypropyl Methylcellulose-HPMC) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Empty Capsules (Other Raw Materials) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Empty Capsules (Other Raw Materials) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Empty Capsules (Immediate-release Capsules) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Empty Capsules (Immediate-release Capsules) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Empty Capsules (Sustained-release Capsules) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Empty Capsules (Sustained-release Capsules) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Empty Capsules (Delayed-release Capsules) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Empty Capsules (Delayed-release Capsules) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Empty Capsules (Antibiotic and Antibacterial Drugs) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Empty Capsules (Antibiotic and Antibacterial Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Empty Capsules (Vitamins and Dietary Supplements) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Empty Capsules (Vitamins and Dietary Supplements) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Global: Empty Capsules (Antacid and Antiflatulent Preparations) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Global: Empty Capsules (Antacid and Antiflatulent Preparations) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Global: Empty Capsules (Cardiovascular Therapy Drugs) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Global: Empty Capsules (Cardiovascular Therapy Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Global: Empty Capsules (Other Therapeutic Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Global: Empty Capsules (Other Therapeutic Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Global: Empty Capsules (Pharmaceutical Industry) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Global: Empty Capsules (Pharmaceutical Industry) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Global: Empty Capsules (Nutraceutical Industry) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Global: Empty Capsules (Nutraceutical Industry) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Global: Empty Capsules (Cosmetics Industry) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Global: Empty Capsules (Cosmetics Industry) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Global: Empty Capsules (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Global: Empty Capsules (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: North America: Empty Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: North America: Empty Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: United States: Empty Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: United States: Empty Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Canada: Empty Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Canada: Empty Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Asia-Pacific: Empty Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Asia-Pacific: Empty Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: China: Empty Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: China: Empty Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Japan: Empty Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Japan: Empty Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: India: Empty Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: India: Empty Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: South Korea: Empty Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: South Korea: Empty Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Australia: Empty Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Australia: Empty Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Indonesia: Empty Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Indonesia: Empty Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Others: Empty Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Others: Empty Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Europe: Empty Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Europe: Empty Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Germany: Empty Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Germany: Empty Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: France: Empty Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: France: Empty Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: United Kingdom: Empty Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: United Kingdom: Empty Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Italy: Empty Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Italy: Empty Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Spain: Empty Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: Spain: Empty Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: Russia: Empty Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 83: Russia: Empty Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 84: Others: Empty Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 85: Others: Empty Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 86: Latin America: Empty Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 87: Latin America: Empty Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 88: Brazil: Empty Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 89: Brazil: Empty Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 90: Mexico: Empty Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 91: Mexico: Empty Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 92: Others: Empty Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 93: Others: Empty Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 94: Middle East and Africa: Empty Capsules Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 95: Middle East and Africa: Empty Capsules Market: Breakup by Country (in %), 2024
  • Figure 96: Middle East and Africa: Empty Capsules Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 97: Global: Empty Capsules Industry: SWOT Analysis
  • Figure 98: Global: Empty Capsules Industry: Value Chain Analysis
  • Figure 99: Global: Empty Capsules Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Empty Capsules Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Empty Capsules Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Empty Capsules Market Forecast: Breakup by Raw Material (in Million USD), 2025-2033
  • Table 4: Global: Empty Capsules Market Forecast: Breakup by Functionality (in Million USD), 2025-2033
  • Table 5: Global: Empty Capsules Market Forecast: Breakup by Therapeutic Application (in Million USD), 2025-2033
  • Table 6: Global: Empty Capsules Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 7: Global: Empty Capsules Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 8: Global: Empty Capsules Market: Competitive Structure
  • Table 9: Global: Empty Capsules Market: Key Players